Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin

Diagnostic Microbiology and Infectious Disease

Volumn 26, Issue 1, 1996, Pages 17-21

  Bonilla, Hector F ^a   Zarins, Lidija T ^a   Bradley, Suzanne F ^a   Kauffman, Carol A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG EFFICACY; ENTEROCOCCUS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; FLUOROQUINOLONES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; METHICILLIN; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; PENICILLINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0030248863     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00146-0     Document Type: Article

References (30)

1. Aldridge KE, Jones RN, Barry AL, Gelfand MS (1992) In vitro activity of various antimicrobial agents against Staphylococcus aureus isolates including fluoroquinolone- and oxacillin-resistant strains. Diagn Microbiol Infect Dis 15:517-521.
2. Arthur M, Courvalin P (1993) Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 37:1563-1571.
3. Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmuth IK (1991) Rapid development of ciprofloxacin resistance in methicillin-susceptible and resistant Staphylococcus aureus. J Infect Dis 163:1279-1285.
4. Briggs-Gooding B, Jones RN (1993) In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone. Antimicrob Agents Chemother 37:349-353.
5. Cohen MA, Yoder SL, Huband MD, Roland GE, Courtney CL (1995) In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 against enterococci. Antimicrob Agents Chemother 39:2123-2127.
6. Daum TE, Schaberg DR, Terpenning MS, Sottile WS, Kauffman CA (1990) Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother 34: 1862-1863.
7. Eliopoulos GM, Klimm K, Eliopoulos CT, Ferraro MJ, Moellering RC (1993) In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of grampositive bacteria. Antimicrob Agents Chemother 37:366-370.
8. Harrington GD, Zarins LT, Ramsey MA, Bradley SF, Kauffman CA (1995) Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to clinafloxacin. Diagn Microbiol Infect Dis 21:27-31.
9. Jones RN (1994) Preliminary interpretive criteria for in vitro susceptibility testing of CP-99219 by dilution and disk diffusion methods. Diagn Microbiol Infect Dis 20: 167-170.
10. Jones RN, Sader HS, Erwin ME, Anderson SC, and the Enterococcus Study Group (1995) Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Diagn Microbiol Infect Dis 21:85-93.
11. Miranda AG, Wanger AR, Singh KV, Murray BE (1992) Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci. Antimicrob Agents Chemother 36:1325-1328.
12. Moellering RC (1992) Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 14:1173-1178.
13. Murray BE (1990) The life and times of the Enterococcus. Clin Microbiol Rev 3:46-65.
14. National Committee for Clinical Laboratory Standards (NCCLS) (1987) Methods for determining bactericidal activity of antimicrobial agents: proposed guidelines M26-P. Villanova, PA: NCCLS.
15. National Committee for Clinical Laboratory Standards (NCCLS) (1993) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A3. Villanova, PA: NCCLS.
16. Neu HC, Chin N-X (1994) In vitro activity of the new fluoroquinolone CP-99,219. Antimicrob Agents Chemother 38: 2615-2622.
17. Perri MB, Chow JW, Zervos MJ (1993) In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci. Diagn Microbiol Infect Dis 17:151-155.
18. Peterson LR, Quick JN, Jensen B, Homan S, Johnson S, Tenquist J, Shanholtzer C, Petzel RA, Sinn L, Gerding DN (1990) Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Arch Intern Med 150:2151-2155.
19. Piddock LJV (1994) New quinolones and gram-positive bacteria. Antimicrob Agents Chemother 38:163-169.
20. Prosser BLT, Beskid G (1995) Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates. Diagn Microbiol Infect Dis 21:33-45.
21. Sahm DF, Koburov GT (1989) In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy. Antimicrob Agents Chemother 33:71-77.
22. Schaberg DR, Culver DC, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91:72S-75S.
23. Schaberg DR, Dillon WI, Terpenning MS, Robinson KA, Bradley SF, Kauffman CA (1992) Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother 36:2533-2535.
24. Schaefler S (1989) Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. J Clin Microbiol 27: 335-336.
25. Scriver SR, Willey BM, Low DE, Simor AE (1993) Comparative in vitro activities of new fluorinated quinolones, clinafloxacin and PD 131628, against staphylococci including ciprofloxacin-resistant strains. Med Microbiol Lett 2:109-115.
26. Strausbaugh LJ, Jacobson C, Sewall DL, Potter S, Ward TT (1992) Antimicrobial therapy for methicillin-resistant Staphylococcus aureus colonization in residents and staff of a veterans affairs nursing home care unit. Infect Control Hosp Epidemiol 13:151-159.
27. Woodford N, Johnson AP, Morrison D, Speller DCE (1995) Current perspectives on glycopeptide resistance. Clin Microbiol Rev 8:585-615.
28. Yamane N, Jones RN (1991) In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin. Diagn Microbiol Infect Dis 14:337-345.
29. Zervos MJ, Bacon AE, Patterson JE, Schaberg DR, Kauffman CA (1988) Enterococcal superinfection in patients treated with ciprofloxacin. J Antimicrob Chemother 21: 113-115.
30. Zervos MJ, Kauffman CA, Therasse PM, Bergman MG, Mikesell TS, Schaberg DS (1987) Nosocomial infection by gentamicin-resistant Streptococcus faecalis: An epidemiologic study. Ann Intern Med 106:687-691.